The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Is guideline-adherent adjuvant treatment an equivalent option for elderly patients who cannot participate in adjuvant clinical breast cancer trials? A retrospective multicenter cohort study of 4,142 patients.
Lukas Schwentner
No relevant relationships to disclose
Reyn Van Ewijk
No relevant relationships to disclose
Theresa Gundelach
No relevant relationships to disclose
Jochem König
No relevant relationships to disclose
Rolf Kreienberg
No relevant relationships to disclose
Wolfgang Janni
No relevant relationships to disclose
Maria Blettner
No relevant relationships to disclose
Achim Wöckel
No relevant relationships to disclose